Neogen Company Top Insiders
| NEOG Stock | USD 10.98 0.17 1.52% |
Neogen employs about 3 K people. The company is managed by 18 executives with a total tenure of roughly 32 years, averaging almost 1.0 years of service per executive, having 165.22 employees per reported executive. Examination of Neogen's management performance can provide insight into the company performance.
| John Adent CEO CEO President |
| Robert Donofrio President Vice President - Food Safety Research and Development |
Neogen Management Team Effectiveness
Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities.The majority of Neogen outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Neogen to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Neogen. Please pay attention to any change in the institutional holdings of Neogen as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as Neogen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Neogen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Neogen Workforce Comparison
Neogen is regarded fourth in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 18,275. Neogen retains roughly 2,974 in number of employees claiming about 16% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.68) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.02) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.02. Neogen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Neogen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
David Naemura over two months ago Disposition of 12912 shares by David Naemura of Neogen at 5.98 subject to Rule 16b-3 | ||
Pelossof Avi over three months ago Insider Trading | ||
John Adent over three months ago Disposition of 3063 shares by John Adent of Neogen at 6.04 subject to Rule 16b-3 | ||
Wainer Andrea F over six months ago Insider Trading | ||
Amy Rocklin over six months ago Disposition of 564 shares by Amy Rocklin of Neogen at 5.16 subject to Rule 16b-3 | ||
Woteki Catherine E over six months ago Acquisition by Woteki Catherine E of 5770 shares of Neogen at 5.17 subject to Rule 16b-3 | ||
Borel James C over six months ago Acquisition by Borel James C of 6075 shares of Neogen at 13.58 subject to Rule 16b-3 | ||
Boehm William T over a year ago Acquisition by Boehm William T of 236 shares of Neogen at 14.89 subject to Rule 16b-3 |
Neogen Notable Stakeholders
A Neogen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Neogen often face trade-offs trying to please all of them. Neogen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Neogen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mike Nassif | President CEO | Profile | |
| Mikhael Nassif | President CEO | Profile | |
| John Adent | CEO President | Profile | |
| Bryan CPA | CFO President | Profile | |
| Robert Donofrio | Vice President - Food Safety Research and Development | Profile | |
| Steven Quinlan | CFO, Principal Accounting Officer, VP and Secretary | Profile | |
| John Moylan | Corporate VP | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Jeremy Yarwood | Chief Officer | Profile | |
| Tamara Ranalli | Senior Safety | Profile | |
| David Naemura | Executive Officer | Profile | |
| Bill Waelke | Head Relations | Profile | |
| Julie Mann | VP Officer | Profile | |
| Kevin Burke | Chief Officer | Profile | |
| Amy Rocklin | Chief Secretary | Profile | |
| Sarah Demey | Administrative Manager | Profile | |
| Joe Freels | Senior Officer | Profile | |
| Douglas Jones | COO VP | Profile |
About Neogen Management Performance
The success or failure of an entity such as Neogen often depends on how effective the management is. Neogen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Neogen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Neogen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.
Neogen Workforce Analysis
Traditionally, organizations such as Neogen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Neogen within its industry.Neogen Manpower Efficiency
Return on Neogen Manpower
| Revenue Per Employee | 300.8K | |
| Revenue Per Executive | 49.7M | |
| Net Loss Per Employee | 367.2K | |
| Net Loss Per Executive | 60.7M | |
| Working Capital Per Employee | 135.5K | |
| Working Capital Per Executive | 22.4M |
Complementary Tools for Neogen Stock analysis
When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |